FARE's Clinical Development Day

FARE's third annual Clinical Development Day took place in Washington, D.C., on October 17-18, 2024, at the Omni Shoreham Hotel, thanks to the generous support of DBV Technologies; Genentech, A member of the Roche Group; Nestle Health Sciences; and Aquestive Therapeutics.

More than 80 attendees were convened on the subject of “Addressing Unmet Needs in Food Allergy: Recent Advances, Ongoing Challenges and Prospects for the Future.” 

Attendees gathered to explore critical issues in the development of new food allergy therapeutics, diagnostics, and prevention strategies. The event was co-chaired by Stephen Tilles, MD, FARE’s Research and Strategic Innovation Advisor, and two FARE Clinical Network investigators, Aikaterini Anagnostou, MD, PhD, and Sarita Patil, MD.

The interactive forum identified key barriers and potential solutions for a number of topical areas including: 

• Early allergen introduction
• Disparities in access to infant-safe forms of allergen-containing foods for prevention
• Inequalities in access to allergist services for diagnosis and treatment
• Challenges to innovators attempting to develop diagnostics and therapeutic
• Uncertainty surrounding best practices for oral immunotherapy
• Fragmented biorepositories

To download the full program, click here.